Cancer screening resident survival guide: Difference between revisions
Jump to navigation
Jump to search
TayyabaAli (talk | contribs) |
TayyabaAli (talk | contribs) |
||
| Line 11: | Line 11: | ||
===Cervical Cancer=== | ===Cervical Cancer=== | ||
===Colorectal Cancer=== | ===Colorectal Cancer=== | ||
*According to the USPSTF (the United States Preventive Services Task Force): Screening for colorectal cancer is recommended among asymptomatic adults older than 50 years of age with no family history of adenoma or colorectal cancer.<ref name="pmid27304597">{{cite journal| author=US Preventive Services Task Force. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW | display-authors=etal| title=Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. | journal=JAMA | year= 2016 | volume= 315 | issue= 23 | pages= 2564-2575 | pmid=27304597 | doi=10.1001/jama.2016.5989 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27304597 }} </ref> | |||
*According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence. Colon cancer is the fourth commonly occurring cancers (6.1% for incidence). It is the third cause of death in cancer patients (9.2% for mortality).<ref name="pmid30207593">{{cite journal| author=Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A| title=Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | journal=CA Cancer J Clin | year= 2018 | volume= 68 | issue= 6 | pages= 394-424 | pmid=30207593 | doi=10.3322/caac.21492 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30207593 }} </ref> | *According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence. Colon cancer is the fourth commonly occurring cancers (6.1% for incidence). It is the third cause of death in cancer patients (9.2% for mortality).<ref name="pmid30207593">{{cite journal| author=Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A| title=Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | journal=CA Cancer J Clin | year= 2018 | volume= 68 | issue= 6 | pages= 394-424 | pmid=30207593 | doi=10.3322/caac.21492 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30207593 }} </ref> | ||
Revision as of 16:27, 3 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
This section provides a short and straight to the point overview of the disease or symptom. The first sentence of the overview must contain the name of the disease.
Common Cancers
Breast Cancer
- Breast cancer screening starts at age ..... via [imaging].
- To view the detailed information on breast cancer screening click here.
Cervical Cancer
Colorectal Cancer
- According to the USPSTF (the United States Preventive Services Task Force): Screening for colorectal cancer is recommended among asymptomatic adults older than 50 years of age with no family history of adenoma or colorectal cancer.[1]
- According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence. Colon cancer is the fourth commonly occurring cancers (6.1% for incidence). It is the third cause of death in cancer patients (9.2% for mortality).[2]
Endometrial Cancer
Esophageal Cancer
Lung Cancer
Ovarian cancer
Prostate Cancer
- ↑ US Preventive Services Task Force. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW; et al. (2016). "Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement". JAMA. 315 (23): 2564–2575. doi:10.1001/jama.2016.5989. PMID 27304597.
- ↑ Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018). "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries". CA Cancer J Clin. 68 (6): 394–424. doi:10.3322/caac.21492. PMID 30207593.